REmote Web Assisted Care for Heart Failure Patients With Implantable Cardioverter Defibrillators
REACH-ICD
Remote Care for Reducing Cardiac Fear, Fear of Dying, Depression, and Increasing Quality of Life in ICD-Patients With Cardiac Insufficiency/at Risk for Fatal Cardiac Arrhythmia.
1 other identifier
interventional
118
1 country
7
Brief Summary
Aim and Background: Although implantable cardioverter defibrillators (ICD) save lives, many ICD-patients experience psychosocial complications such as anxiety disorders, depression and reduced quality of life after ICD-implantation. A recent review has indicated great potential for psychosocial interventions to reduce anxiety and to increase exercise capacity of ICD-patients. In a previous study, the investigators showed that mailed information about technical, medical and psychological effects of ICD plus phone counseling are effective interventions for reducing anxiety, psychological distress and increasing QoL in ICD-patients \< 65 years. In a pilot study the investigators also documented promising effects of an internet based intervention with similar content. Method: In a prospective, multicenter, multidisciplinary, half-open, part-randomized, controlled clinical trial N = 200 patients with an ICD will either receive medical care as usual or additionally attend a psychosocial prevention program via remote care. Psychosocial support will be provided utilizing the advantages of the internet. Thus, patient-centered support will be offered independent from time and location. Outcome measures are psychometric data (questionnaires on cardiac fear, etc.), cardiac functioning, and clinical status which will be assessed up to 1 week before ICD-implantation (T0), in week 1 (T1) and within one week after (T2) the 6-weeks prevention program, and 12 months after T0 (T3). Furthermore, demographic data, personality characteristics, expectations, physiology, pro-inflammatory cytokines and cardiac status will be assessed as mediating or moderating variables. Hypotheses: A web-based psychosocial intervention in addition to medical care as usual leads to increased QoL and reduced anxiety and depression. Secondary goals are the identification of psychosocial and medical predictors, mediators, and moderators of treatment efficacy. Moreover, differences between patients with ICDs implanted for primary vs. secondary prevention will be explored. Conclusion: This project will evaluate the feasibility and efficacy of an internet based intervention for ICD-patients. Furthermore, the investigators aim at identifying predictors and mediators of treatment outcome. This will improve interdisciplinary care for ICD-patients; further applications for other cardiovascular disorders as well as preventive programs for heart failure seem possible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started May 2012
Longer than P75 for not_applicable anxiety
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2011
CompletedStudy Start
First participant enrolled
May 1, 2012
CompletedFirst Posted
Study publicly available on registry
May 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedMay 1, 2019
April 1, 2019
3.2 years
October 5, 2011
April 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change of psychosocial well-being (combined score for measures of anxiety, depression, and quality of life) from week 1 (T1) to one week after (T2) the 6-weeks prevention program
assessment tools for aspects of psychosocial well-being (German versions will be used): Anxiety: Cardiac Fear Questionnaire (Hoyer \& Eifert, 2001); Depression: Hospital Anxiety and Depression Scale (Hinz \& Brähler, 2011); QoL: MOS 36-item short-form health survey (Ware \& Sherbourne, 1992)
up to 1 week before ICD-implantation (T0), in week 1 (T1) and within one week after (T2) the 6-weeks prevention program, and 12 months after T0 (T3)
Secondary Outcomes (3)
1. Health status 2. ICD-related trauma 3. Life-style factors 4. ICD-Related concerns 5. Psychological well-being 6. Type-D personality 7. Social support 8. Economic efficiency
up to 1 week before ICD-implantation (T0), in week 1 (T1) and within one week after (T2) the 6-weeks prevention program, and 12 months after T0 (T3)
psychophysiological parameters: heart rate variability
up to 1 week before ICD-implantation (T0) and 1, 3, 6, and 12 months after ICD-implantation
biometric markers: 1. proinflammatory cytokines 2. coagulation parameters
up to 1 week before ICD-implantation (T0) and 6 months after ICD-implantation
Study Arms (2)
Treatment as usual plus remote care
EXPERIMENTALThe same treatment as described under "treatment as usual" plus participation in the intervention "ICD-Forum".
Treatment as usual
NO INTERVENTIONStandard information provided by hospitals on ICD-technology as well as consequences of ICD-implantation plus medical aftercare including cardiology appointments at 1, 3, and 6 months, and one year after ICD-implantation.
Interventions
The CBT based internet program ICD-Forum is designed to increase QoL, and decrease anxiety and depression in ICD-patients. The program includes a therapist moderated asynchronous discussion group and content focused modules following a six weeks schedule: 1. Introduction to participants and online system 2. Knowledge regarding ICDs 3. Strategies for behavior change 4. Psychological models for anxiety and depression 5. Strategies to cope with avoidance, anxiety and depression 6. Resume, evaluation, resolution of open questions, goal setting, good bye
Eligibility Criteria
You may qualify if:
- Implanted ICD
- Internet access can be installed during completion of the prevention program
You may not qualify if:
- Medical reasons preventing participation of the prevention program (e.g. emergency hospitalization) for more than one week of the program
- Suicidality (Patients with scores \> 8 on the depression subscale of the HADS will be assessed via interviews conducted by a qualified psychologist)
- Severe cognitive impairment (\< 17 points in the MMST; Kessler, J., Markowitsch, H. J. \& Denzler, P. (2000). Mini-Mental-Status-Test (MMST). Göttingen: Beltz Test GMBH. \[Deutsche Adaption\])
- Insufficient command of German to follow the intervention program
- Current ICD-10 diagnosis:
- F1x: Mental and behavioral disorders due to psychoactive substance use
- F2x: Schizophrenia, schizotypal and delusional disorders
- F30: Manic Episode
- F31: Bipolar affective disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wuerzburg University Hospitallead
- University of Wuerzburgcollaborator
- Campus Bad Neustadtcollaborator
- Hospital Rothenburg ob der Taubercollaborator
- University Hospital Brandenburgcollaborator
- Klinikum Aschaffenburg-Alzenaucollaborator
- Klinikum Bad Woerishofencollaborator
- University of Leipzigcollaborator
Study Sites (7)
Department of Cardiology, Center of Cardiovascular Medicine
Bad Neustadt an der Saale, Bavaria, 97616, Germany
Klinik Bad Wörishofen
Bad Wörishofen, Bavaria, 86825, Germany
Department of Internal Medicine, Krankenhaus Rothenburg ob der Tauber
Rothenburg upon Tauber, Bavaria, 91541, Germany
University of Wuerzburg
Würzburg, Bavaria, 97070, Germany
Wuerzburg University Hospital, Department of Medicine I (Cardiology)
Würzburg, Bavaria, 97080, Germany
Klinikum Aschaffenburg-Alzenau
Aschaffenburg, Hesse, 63739, Germany
Klinik für Kardiologie und Pulmologie, Medizinische Hochschule Brandenburg
Brandenburg, 14770, Germany
Related Publications (3)
Schulz SM, Pauli P. [Internet therapy for ICD-patients]. Herzschrittmacherther Elektrophysiol. 2011 Sep;22(3):166-73. doi: 10.1007/s00399-011-0145-y. German.
PMID: 21826541BACKGROUNDSchulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety. Heart Lung. 2013 Mar-Apr;42(2):105-11. doi: 10.1016/j.hrtlng.2012.08.006. Epub 2012 Oct 27.
PMID: 23110854BACKGROUNDSchulz SM, Ritter O, Zniva R, Nordbeck P, Wacker C, Jack M, Groschup G, Deneke T, Puppe F, Ertl G, Angermann C, Stork S, Pauli P. Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial. Eur Heart J. 2020 Mar 14;41(11):1203-1211. doi: 10.1093/eurheartj/ehz134.
PMID: 30957867RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Pauli, Prof. Dr.
University of Würzburg
- PRINCIPAL INVESTIGATOR
Stefan M Schulz, Dr.
University of Würzburg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2011
First Posted
May 2, 2012
Study Start
May 1, 2012
Primary Completion
July 1, 2015
Study Completion
August 1, 2016
Last Updated
May 1, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share